Pharmozyme Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Pharmozyme's estimated annual revenue is currently $1.9M per year.(i)
  • Pharmozyme's estimated revenue per employee is $155,000

Employee Data

  • Pharmozyme has 12 Employees.(i)
  • Pharmozyme grew their employee count by -8% last year.

Pharmozyme's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
Founder & ChairmanReveal Email/Phone
3
Head OperationsReveal Email/Phone
4
Head OperationsReveal Email/Phone
5
Research Lab Director and ScientistReveal Email/Phone
6
Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Pharmozyme?

Pharmozyme currently specializes in a new and improved one-step SARS-COV-2 one step RT-qPCR detection Kit for the detection of SARS-CoV-2(2019-nCoV) viral RNA by targeting the E & N2 genes. A rapid molecular diagnostic tool to detect SARS-CoV-2 causing Covid-19 in patients. Founded in 2013, Co-founder Dr. Nader Nourizad, A pioneer in pyrosequencing and reagent engineering, believed the market was in desperate need of high quality, high yield, and above all else, truly pure reagents. Pharmozyme has since developed proprietary technology to produce the world’s purest reagents, introducing the world’s first Taq Polymerase free from bacterial and animal DNA contamination. In the coming years Pharmozyme plans to release a variety of contamination free reagents, supporting new technologies in sequencing and DNA research. Its future path will include the production of highly accurate and sensitive kits for medical diagnostics. Pharmozyme’s mission is to significantly improve the lives of human beings through the development of novel, effective, and accessible solutions for the biotech community.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1.9M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.9M120%N/A
#2
$1M120%N/A
#3
$1.5M12-33%N/A
#4
$0.9M129%$14.3M
#5
$1M12-14%N/A